Back to Authors

Toskich, Beau B.

https://orcid.org/0000-0003-4707-7921

Mayo Clinic

Mayo Clinic in Florida

Citations 29

Advancements in Locoregional Therapies for Unresectable Intrahepatic Cholangiocarcinoma
O'Donnell, C. , Rutenberg, Michael, Croome, Kristopher P. , Poruk, Katherine E. , Toskich, Beau B. , Jin, Zhaohui , O'Donnell, Conor D J , Rutenberg, Michael , Croome, Kris P , Jin, Zhaohui , Majeed, Umair

Current Oncology | January 31, 2025 | Volume: 32 | Issue: 2 | Pages: 82

10.3390/curroncol32020082 Get It

Intrahepatic cholangiocarcinoma is an aggressive malignancy with rising incidence and poor outcomes. This review examines recent advancements in locoregional therapies for unresectable intrahepatic cholangiocarcinoma, focusing on external beam radiotherapy, transarterial radioembolization (TARE), hepatic artery infusion pump (HAIP) chemotherapy, and liver transplantation. Stereotactic body radiation therapy and proton beam therapy have shown promise in achieving local control and improving survival. TARE, with personalized dosimetry, has demonstrated encouraging results in select patient populations. HAIP chemotherapy, primarily studied using floxuridine, has yielded impressive survival outcomes in phase II trials. Liver transplantation, once contraindicated, is now being reconsidered for carefully selected patients with localized disease. While these locoregional approaches show potential, randomized controlled trials comparing them to standard systemic therapy are lacking. Patient selection remains crucial, with factors such as liver function, tumor burden, and molecular profile influencing treatment decisions. Ongoing research aims to optimize treatment sequencing, explore combination strategies with systemic therapies, and refine phenotype identification and patient selection criteria. As the landscape of intrahepatic cholangiocarcinoma management evolves, a multidisciplinary approach is essential to tailor treatment strategies and improve outcomes for patients with this challenging disease.
Radiation Segmentectomy for the Treatment of Hepatocellular Carcinoma: A Practical Review of Evidence
Mourad, Sophia N., Toskich, Beau B. , Garza‐Ramos, Cynthia De la

Cancers | February 6, 2024 | Volume: 16 | Issue: 3 | Pages: 669

10.3390/cancers16030669 Get It

Radiation segmentectomy is a versatile, safe, and effective ablative therapy for early-stage hepatocellular carcinoma. Advances in radiation segmentectomy patient selection, procedural technique, and dosimetry have positioned this modality as a curative-intent and guideline-supported treatment for patients with solitary HCC. This review describes key radiation segmentectomy concepts and summarizes the existing literary knowledgebase.
A secondary daily persistent headache from onset with underlying nutcracker physiology and spinal epidural venous congestion: case series with lumbar vein embolization as a therapeutic approach
Rozen, Todd D. , Devcic, Zlatko , Lewis, Andrew R. , Toskich, Beau , Toskich, Beau B. , Sandhu, Sukhwinder J.S. , Erben, Young

Therapeutic Advances in Neurological Disorders | November 23, 2023 | Volume: 16 | Issue: No issue available | Pages: No page available

10.1177/17562864231213243 Get It

The authors have published on a unique subset of patients whose headaches worsened in the Trendelenburg position and who on time-resolved MR angiography demonstrated left renal vein compression (nutcracker physiology) with retrograde left second lumbar vein (L2LV) flow and regional spinal epidural venous plexus (EVP) congestion. We hypothesized that the spinal EVP congestion subsequently causes a secondary congestion of the cerebral venous system, which then leads to an elevation of CSF pressure above that individuals CSF pressure set point. This results in a daily headache from onset. Thus, eliminating the spinal EVP could conceivably improve or eliminate the manifested headache syndrome. We now present a case series of four patients with long-term follow-up utilizing lumbar vein coil embolization as a new therapeutic approach. In each patient, the MR angiography findings were verified by catheter-based venography. Treatment consisted of endovascular embolization of the second lumbar vein. Four patients have had coil embolization of which three are 1 year or longer from their procedure while one is 10 months posttreatment. All patients were women. Duration of daily headache prior to embolization ranged from 4 to 8 years. Post-embolization: Three patients are either headache free or 90–95% improved with substantial pain free time. There were no procedure-related complications. Our results suggest that embolization of L2LV in a specific patient population with nutcracker physiology may substantially improve head pain issues. This is a minimally invasive outpatient technique with no apparent side effects.
Transarterial Radioembolization: Overview of Radioembolic Devices
Serhal, Muhamad , Gordon, Andrew C. , Toskich, Beau , Lewandowski, Robert J. , Toskich, Beau B. , Brown, Daniel B.

Seminars in Interventional Radiology | November 2, 2023 | Volume: 40 | Issue: 05 | Pages: 461-466

10.1055/s-0043-1772814 Get It

Prospective evaluation of lymphatic embolization as part of the treatment in dogs with presumptive idiopathic chylothorax
Carvajal, Jose L. , Case, J. Brad , Grosso, Federico R. Vilaplana , Fox‐Alvarez, W. Alexander, Regier, Penny J. , Verpaalen, Valentine D. , Toskich, Beau B. , Verpaalen, Valentine

Veterinary Surgery | June 13, 2022 | Volume: 51 | Issue: S1 | Pages: No page available

10.1111/vsu.13825 Get It

AbstractObjectiveTo describe the embolization technique and short‐term clinical outcome in dogs undergoing lymphatic embolization (LE) as part of treatment for presumptive idiopathic chylothorax (IC). Additionally, to document findings in computed tomography lymphangiography (CTLa) following embolization.Study designProspective case series.AnimalsEight client‐owned dogs.MethodsDogs underwent CTLa followed by thoracic duct ligation (TDL), pericardiectomy (PC) and LE. A mixture of 3:1 lipiodol: n‐butyl cyanoacrylate embolic solution was injected through a catheterized mesenteric lymphatic vessel via limited abdominal approach using intraoperative fluoroscopy. CTLa was scheduled for 12 weeks postoperatively, and long‐term follow‐up was obtained via telephone contact.ResultsLE was technically successful in six of the eight dogs; and clinically successful in five of the six dogs. In the unsuccessful dog, a diagnosis of lymphangiosarcoma was determined, and the owners elected for euthanasia. Five dogs who underwent successful LE underwent CTLa at 12 weeks. Complete resolution of pleural effusion occurred in three dogs and scant pleural effusion in two dogs. A robust lymphatic embolus preventing antegrade continuation of radiocontrast was documented in all five dogs. Five of the six dogs that underwent LE, were alive and clinically normal at 358–960 days postoperatively.ConclusionsLE is a feasible part of treatment for dogs with IC. Additionally, a robust lymphatic embolus and lack of radiocontrast flow past the embolus was documented at 12 weeks following surgery.Clinical significanceLE has the potential to reduce surgical failure by reducing efferent lymphatic chyle flow, occluding missed lymphatic branches and preventing the development of collateral branches.
Focal Nodular Hyperplasia and Focal Nodular Hyperplasia–like Lesions
LeGout, Jordan D. , Bolan, Candice W. , Bowman, Andrew W. , Caserta, Melanie P. , Chen, Frank K. , Cox, Kelly , Sanyal, Rupan , Toskich, Beau B. , Lewis, Jason T., Alexander, Lauren F. , Bowman, Andrew W , Alexander, Lauren F , Toskich, Beau , Lewis, Jason T.

RadioGraphics | June 10, 2022 | Volume: 42 | Issue: 4 | Pages: 1043-1061

10.1148/rg.210156 Get It

Radioembolization for the Treatment of Hepatocellular Carcinoma: The Road to Personalized Dosimetry and Ablative Practice
Garza‐Ramos, Cynthia De la , Toskich, Beau B. , De la Garza-Ramos, Cynthia, De la Garza-Ramos, Cynthia

Seminars in Interventional Radiology | October 7, 2021 | Volume: 38 | Issue: 04 | Pages: 466-471

10.1055/s-0041-1735571 Get It

AbstractRadioembolization dosimetry for the treatment of hepatocellular carcinoma has evolved alongside our understanding of best practice for this therapy. At the core of advances in dosimetry are personalized and ablative applications of radioembolization, which have generated paradigm shifts in both safety and efficacy. This review provides a summary of fundamental radioembolization dosimetry concepts and narrates how our approach to treating patients has shifted from conventional to tailored and definitive therapy.
Acute Mesenteric Ischemia Remains a Highly Morbid Diagnosis after Initial Hospitalization Survival
Spaulding, Aaron , Oderich, Gustavo S. , Rocha-Franco, Joao A. Da, Farres, Houssam , Cochuyt, Jordan J., Sorrells, William S., Oldenburg, A, Frey, G. , Toskich, Beau B. , Becher, Robert D. , Hakaim, Albert G., Spaulding, Aaron , Erben, Young , Oderich, Gustavo S. , Oldenburg, A. W.

International Journal of Angiology | March 5, 2020 | Volume: 29 | Issue: 03 | Pages: 189-195

10.1055/s-0039-1700984 Get It

AbstractAcute mesenteric ischemia (AMI) remains a vascular emergency. Our aim was to explore readmission for AMI. We identified all patients admitted for AMI from the state of California through the Healthcare and Utilization Project from 2005 to 2011. Our primary end point was the rate and etiology for readmission. Our secondary end points were the length of hospitalization and in-hospital mortality. Cox proportional hazard regression was utilized to assess risk of 30-day readmission. There were 534 (9.9%) readmissions at 30 days. The mean age was 67 ± 17 years and 209 (39.1%) were male. The five most common etiologies for readmission were AMI (7.6%), cardiac events (5.3%), severe sepsis (1.2%), dehydration (1.1%), and acute kidney failure (1.1%). Once readmitted, these patients were most likely to experience cardiac catheterizations (25.4%), red blood cell transfusions (23.6%), intubation and mechanical ventilation (17.6%), biopsy of the large intestine (13.9%), reoperation for small bowel resection (10.9%), administration of total parenteral nutrition (10.5%), and transfusion of other blood products (6.9%). This hospitalization was 8.8 ± 12.7 days long. In-hospital mortality was 36 patients (6.7%). On multivariable Cox-regression analysis, severe (hazard ratio [HR]: 2.1 [1.4–3.2], p = 0.0005) and moderate (HR: 1.5 [1.03–2.13], p = 0.04) Elixhauser Comorbidity Group, complications (HR: 1.5 [1.2–1.9], p = 0.0007), and longer index hospitalization (HR: 1.02 [1.01–1.02], p < 0.0001) were predictors of readmission. Conclusion AMI remains a vascular emergency. Readmissions have a significant rate of morbid invasive procedures and can lead to an in-hospital mortality of 6.7%. The adoption of guidelines similar to the European Society for Trauma and Emergency Surgery should be considered.
Renal artery injury during inferior vena cava filter removal with endobronchial forceps
Padula, Carlos A. , Lewis, Andrew R. , Frey, G. , McKinney, J. Mark , Paz‐Fumagalli, Ricardo , Ritchie, Charles , Devcic, Zlatko , Toskich, Beau B. , Frey, Gregory T, Ritchie, Charles A

JRSM Cardiovascular Disease | December 4, 2019 | Volume: 8 | Issue: No issue available | Pages: No page available

10.1177/2048004019893513 Get It

Retrieval of tip-embedded inferior vena cava filters using endobronchial forceps is a well-described technique. The tip of dorsally tilted filters may be in proximity to the right renal artery, increasing the risk of arterial injury during retrieval. We present one case that illustrates renal artery injury requiring emergent stent graft repair. The three subsequent cases illustrate techniques that avoid renal artery injury using a femoral and jugular approach with the assistance of an arterial fiducial wire. Renal artery injury is a potential complication during retrieval of filters using endobronchial forceps that can be prevented with careful planning.
Ablation and the Art of In Situ Tissue Elimination
Toskich, Beau , Toskich, Beau B.

Seminars in Interventional Radiology | December 2, 2019 | Volume: 36 | Issue: 05 | Pages: 349-350

10.1055/s-0039-3401331 Get It